We have located links that may give you full text access.
OPEs-ID: A software for non-targeted screening of organophosphate esters based on liquid chromatography-high-resolution mass spectrometry.
Journal of Hazardous Materials 2023 December 16
Organophosphate esters (OPEs) are widely used as flame retardants and plasticizers, presenting a potential threat to the environment and human health. To date, no automatic software exists for the nontargeted screening of OPEs. In this study, OPEs-ID, a user-friendly software, was developed for the identification of OPEs using liquid chromatography-high-resolution mass spectrometry. The main workflow of OPEs-ID included fragments-dependent precursor ion screening, elemental composition determination, extracted ion chromatograms (EIC) comparison, and molecular structure identification via MetFrag strategy. A mixture of 17 OPE standards was identified with an identification rate of 100% by OPEs-ID. OPEs-ID demonstrated a rate of 94.1% for correctly ranking within the top 1 candidate in a local database (41.2% in PubChem) for the 17 OPE standards, which remarkably improved the identification when compared to conventional in silico fragmentation algorithms. Using a pooled airborne fine particle sample (PM2.5 ), OPEs-ID could automatically retrieve 22 valid molecules with structure candidates. The detection frequencies of 9 newly identified OPEs were between 13% and 100% in the 32 PM2.5 samples. Their semi-quantification concentrations were comparable to those of some traditional OPEs. Overall, OPEs-ID offers a powerful tool to significantly enrich our understanding of the OPEs present in the environment.
Full text links
Related Resources
Trending Papers
Review article: Recent advances in ascites and acute kidney injury management in cirrhosis.Alimentary Pharmacology & Therapeutics 2024 March 26
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app